RICHMOND, British Columbia, June 12, 2008 (PRIME NEWSWIRE) -- Following the completion of its successful testing on bladder, kidney, stomach and other types of cancer, BioCurex (OTCBB:BOCX) is pleased to announce that its ELISA technology can now move Biocurex towards early commercialization of its proprietary RECAF cancer-detection.
